Cystatin SN activators constitute a specialized class of chemical compounds recognized for their ability to modulate the activity of Cystatin SN, a member of the cystatin superfamily of proteins. Cystatins are naturally occurring protein inhibitors that play a critical role in regulating protease activity within cells and tissues. Specifically, Cystatin SN is involved in inhibiting the activity of cysteine proteases, a group of enzymes crucial for protein degradation and cellular processes. These activators are meticulously designed to interact with Cystatin SN, potentially influencing its inhibitory function and affecting downstream protease activity. At the molecular level, the mechanisms through which Cystatin SN activators exert their effects can be complex, often involving binding to specific regions of the protein or modulating its interactions with target proteases.
The study of Cystatin SN activators is pivotal for advancing our understanding of intracellular protease regulation and the intricate mechanisms that govern protein turnover and cellular homeostasis. Researchers in this field primarily focus on elucidating the precise molecular mechanisms by which these compounds impact Cystatin SN's inhibitory function and their downstream effects on protease activity. Understanding the role of Cystatin SN activators contributes to our broader knowledge of cellular biology and the intricate proteolytic processes that maintain cellular homeostasis. Moreover, these compounds serve as valuable tools for scientists seeking to investigate the molecular basis of protease inhibition and its implications in various physiological and pathological contexts, ultimately deepening our understanding of protease regulation and its role in cellular processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
Involved in inflammation and cancer; might modulate cystatin SN expression in these contexts. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
Hormone modulating various cellular processes; potential influence on cystatin SN in estrogen-responsive tissues. | ||||||
Butyric acid | 107-92-6 | sc-214640 sc-214640A | 1 kg 10 kg | $64.00 $177.00 | ||
Histone deacetylase inhibitor; might modulate cystatin SN expression through epigenetic mechanisms. | ||||||
Hydrogen Peroxide | 7722-84-1 | sc-203336 sc-203336A sc-203336B | 100 ml 500 ml 3.8 L | $31.00 $61.00 $95.00 | 28 | |
Reactive oxygen species; might modulate cystatin SN during oxidative stress responses. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $120.00 $326.00 $634.00 $947.00 $1259.00 | 38 | |
PPARγ agonist; potential influence on cystatin SN in metabolic contexts. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Glucocorticoid; might modulate cystatin SN expression in immune cells or during anti-inflammatory responses. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Phytoestrogen; potential effects on cystatin SN in contexts where estrogen signaling is relevant. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
MAPK/ERK inhibitor; could influence cystatin SN through the MAPK signaling pathway. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor; might modulate cystatin SN expression through the PI3K/Akt pathway. | ||||||